MDT · News · 20261101N

Cardiac Ablation Clinical Evidence

Medtronic plc · 2026-11-01 · Importance 17 · Surprise 24

Medtronic reported positive real-world outcomes for its Affera Mapping and Ablation System among patients with atrial fibrillation and ventricular tachycardia. The company also highlighted favorable real-world data for its PulseSelect Pulsed Field Ablation System across a broad cardiac ablation patient group. The report provided no numerical outcomes or specific patient counts.

Key facts

• Medtronic reported positive real-world outcomes for its Affera Mapping and Ablation System in patients with atrial fibrillation and ventricular tachycardia. source
• Medtronic highlighted favorable real-world data for its PulseSelect Pulsed Field Ablation System across a broad cardiac ablation patient group. source